Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
39469374 | 0 | Khan F, Varma A, Negandhi PK, et al. A Comprehensive Review of Cryptogenic Stroke and Atrial Fibrillation: Real-World Insights Into the Role of Insertable Cardiac Monitors. Cureus. 2024 Sep 28;16(9):e70369. doi: 10.7759/cureus.70369. eCollection 2024 Sep. | |
39239346 | 0 | Khan F, Carrier M, Rochwerg B. Assessing the Certainty of Evidence on Efficacy and Safety of Anticoagulants for Cancer-Associated Thrombosis. JACC CardioOncol. 2024 Jul 2;6(4):622-623. doi: 10.1016/j.jaccao.2024.03.014. eCollection 2024 Aug. | |
38563897 | 0 | Khan F, Tran A, Carrier M. ICU-specific factors associated with venous thromboembolism and bleeding. Intensive Care Med. 2024 Apr 2. doi: 10.1007/s00134-024-07395-7. | |
38466279 | 0 | Khan F, Lun R, Hill MD. Inconclusive Findings in Non-Vitamin K Antagonist Oral Anticoagulants Study. JAMA Intern Med. 2024 May 1;184(5):583-584. doi: 10.1001/jamainternmed.2024.0091. | |
37801772 | 0 | Xu Y, Khan F, Kovacs MJ, et al. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study. Thromb Res. 2023 Sep 26;231:32-38. doi: 10.1016/j.thromres.2023.09.012. | |
37364263 | 0 | Khan F, Coyle D, Thavorn K, et al. Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study. Ann Intern Med. 2023 Jun 27. doi: 10.7326/M22-3559. | |
36609323 | 0 | Khan F, Thavorn K, Coyle D, et al. Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism. BMJ Open. 2023 Jan 6;13(1):e053927. doi: 10.1136/bmjopen-2021-053927. | |
36514164 | 0 | Chornenki NLJ, Tritschler T, Stucki F, et al. All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis. Syst Rev. 2022 Dec 13;11(1):269. doi: 10.1186/s13643-022-02146-5. | |
35679460 | 0 | Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027. | |
35157815 | 0 | Khan F, Tritschler T, Le Gal G, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. Ann Intern Med. 2022 Feb;175(2):W14. doi: 10.7326/L21-0731. | |
34753191 | 0 | Khan F, Rahman A, Tritschler T, et al. Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis. Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728. | |
34516270 | 0 | Khan F, Tritschler T, Kimpton M, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis. Ann Intern Med. 2021 Oct;174(10):1420-1429. doi: 10.7326/M21-1094. Epub 2021 Sep 14. | |
34379859 | 0 | Khan F, Tritschler T, Kimpton M, et al. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Nov;19(11):2801-2813. doi: 10.1111/jth.15491. Epub 2021 Aug 22. | |
33984268 | 0 | Khan F, Tritschler T, Kahn SR, et al. Venous thromboembolism. Lancet. 2021 Jul 3;398(10294):64-77. doi: 10.1016/S0140-6736(20)32658-1. Epub 2021 May 10. | |
32579570 | 0 | Yogendrakumar V, Lun R, Khan F, et al. Venous thromboembolism prevention in intracerebral hemorrhage: A systematic review and network meta-analysis. PLoS One. 2020 Jun 24;15(6):e0234957. doi: 10.1371/journal.pone.0234957. eCollection 2020. | |
31661033 | 0 | Khan F, Kimpton M, Tritschler T, et al. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol. Syst Rev. 2019 Oct 28;8(1):245. doi: 10.1186/s13643-019-1175-5. | |
31340984 | 0 | Khan F, Rahman A, Carrier M, et al. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis. BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363. | |
30322987 | 0 | Khan F, Ramirez FD, Hibbert B. Percutaneous left atrial appendage closure for managing thromboembolic risk in atrial fibrillation. CMAJ. 2018 Oct 15;190(41):E1227-E1230. doi: 10.1503/cmaj.180470. | |
30046669 | 0 | Khan F, Rahman A, Carrier M. Occult cancer detection in venous thromboembolism: the past, the present, and the future. Res Pract Thromb Haemost. 2017 Jun 16;1(1):9-13. doi: 10.1002/rth2.12007. eCollection 2017 Jul. | |
29440340 | 0 | Khan F, Le Gal G, Rodger MA. The authors respond to "Thrombophilia testing in venous thromboembolism". CMAJ. 2018 Feb 12;190(6):E172. doi: 10.1503/cmaj.68991. | |
28939565 | 0 | Khan F, Rahman A, Carrier M, et al. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis. BMJ Open. 2017 Sep 21;7(9):16950. doi: 10.1136/bmjopen-2017-016950. | |
28874432 | 0 | Khan F, Le Gal G, Rodger MA. Stopping anticoagulation in a woman with unprovoked venous thromboembolism. CMAJ. 2017 Sep 5;189(35):E1112-E1114. doi: 10.1503/cmaj.170327. | |
28566284 | 0 | Khan F, Vaillancourt C, Bourjeily G. Diagnosis and management of deep vein thrombosis in pregnancy. BMJ. 2017 May 31;357:j2344. doi: 10.1136/bmj.j2344. | |
28330840 | 0 | Khan F, Vaillancourt C, Carrier M. Should we screen extensively for cancer after unprovoked venous thrombosis? BMJ. 2017 Mar 22;356:j1081. doi: 10.1136/bmj.j1081. | |
27159419 | 0 | Khan F, Carrier M, Rodger M. Cancer Screening After Unprovoked Venous Thromboembolism: A Teachable Moment. JAMA Intern Med. 2016 Jun 1;176(6):739-40. doi: 10.1001/jamainternmed.2016.1783. |